Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PeriZone is the oral health division of MIS Implants Technologies (a subsidiary of Dentsply Sirona), specializing in the development and commercialization of non-invasive oral care products. The division's flagship product, PerioPatch, is a hydrogel-based oral wound barrier designed to protect inflamed or injured gingival tissue and promote natural healing by absorbing wound exudates. Launched in 2011, PeriZone leverages advanced hydrogel technology and botanical extracts to provide symptomatic relief and accelerate tissue repair for conditions such as periodontitis, stomatitis, and oral trauma. The brand aims to provide dental professionals with innovative, clinically-proven solutions that complement traditional periodontal treatments like scaling and root planing. PeriZone's products are developed in collaboration with Izun Pharmaceuticals and are designed to rebalance the oral environment by removing inflammatory fluids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PeriZone.